Jimini Health is a technology company.
Jimini Health has raised $8.0M across 1 funding round.
Jimini Health has raised $8.0M in total across 1 funding round.
Jimini Health has raised $8.0M in total across 1 funding round.
Jimini Health's investors include LionBird, Zetta Venture Partners.
Jimini Health is a San Francisco-based mental health technology company that builds an AI-augmented therapy platform featuring Sage, a clinician-supervised AI assistant enabling continuous care between sessions.[1][2][3] It serves patients with mental health conditions and their human therapists, solving the problem of stagnant therapy outcomes by blending evidence-based modalities like cognitive behavioral therapy with daily, personalized AI support that delivers up to 2x greater effect sizes than traditional online therapy.[1][2] Recently launched with $8M in funding, Jimini focuses on scaling its AI, data, safety operations, and products for initial clients, prioritizing clinical rigor over general-purpose chatbots.[2][5]
Jimini Health emerged from the recognition that advanced biotech like mRNA and cell therapies have transformed healthcare, yet therapy practices remain outdated.[1] Co-founded by Luis Voloch (ex-co-founder of Immunai, a $1B+ AI-driven cancer immunotherapy firm), Mark Jacobstein (ex-Guardant Health, Immunai), and Sahil Sud (ex-Ribbon Health, Palantir), the team combines AI, biotech, and healthcare expertise to create a clinician-led model.[2] Operating in stealth from San Francisco, Jimini launched publicly in December 2024 with $8M funding from investors including Zetta Venture Partners and PsyMed Ventures, marking early traction through peer-reviewed validation of its continuous care approach.[2][5]
Jimini rides the AI-in-healthcare wave, specifically targeting behavioral health where LLMs promise transformation but pose risks without clinical safeguards—positioning it amid surging demand for mental health tech post-pandemic.[1][2] Timing aligns with maturing AI tools and investor interest, as seen in its $8M seed from AI/health-focused VCs like Zetta, amid a market favoring hybrid human-AI models over pure automation.[2][5] Favorable forces include scalability of continuous care (unfeasible manually) and evidence backing AI augmentation, influencing the ecosystem by setting standards for responsible AI in therapy and enabling high-touch care at population scale.[1][3]
Jimini Health is poised to redefine mental health by scaling Sage's hybrid model, with funding earmarked for AI enhancements, safety ops, and client expansion—potentially capturing share in a fragmented teletherapy market.[2] Trends like advanced LLMs, regulatory pushes for AI safety, and continuous care adoption will propel growth, evolving its influence from stealth innovator to ecosystem leader in clinician-empowered AI therapy. This positions Jimini to deliver the modern patient journey it promises, bridging tech's potential with clinical reality.[1][2]
Jimini Health has raised $8.0M across 1 funding round. Most recently, it raised $8.0M Seed in November 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2024 | $8.0M Seed | LionBird, Zetta Venture Partners |